Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

PHASE4CompletedINTERVENTIONAL

Enrollment

454

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

October 31, 2004

Conditions

Placental Malaria InfectionHIV InfectionsStillbirthPrematurityNeonatal Deaths

Interventions

DRUG

Sulfadoxine-pyrimethamine (Fansidar)

Trial Locations (1)

Tropical Diseases Research Centre, Ndola

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

Center for International Health and Development

OTHER

NCT00270530 - Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia | Biotech Hunter | Biotech Hunter